27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Enveric Biosciences, Inc. (NASDAQ:ENVB) shares nearly doubled Wednesday afternoon after the company received its second notice of allowance regarding its patent application related to its EVM201 series.
What To Know: Notices of Allowance are issued by the United States Patent and Trademark Office (USPTO) after it has made a determination that a patent should be granted. It's likely that the company's patent titled, "C4-Carboxylic Acid-Substituted Tryptamine Derivatives and Methods of Using," will be issued soon.
This patent is structurally different than the company's other recently announced notice of allowance and covers a composition of matter claims for a family of novel prodrug derivatives of psilocin.
"This latest Notice of Allowance related to our EVM201 Series highlights the unique psilocin prodrug designs being developed by our R&D team, which are differentiated from other psilocybin-assisted therapies in both design and expected function," said Joseph Tucker, director and CEO of Enveric.
"Securing intellectual property to protect our technological advances is a critical component to our growth strategy, and we anticipate multiple additional claims in the coming months for both our EVM201 and EVM301 Series."
Related Link: Enveric Biosciences Announces Publication of Four Patent Applications for Psychedelic-Inspired Drug Candidates
ENVB Price Action: Enveric Biosciences shares were up 98.1% at $6.24 at the time of this publication according to Benzinga Pro.
Photo: Steve Buissinne from Pixabay
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!